Original Research
Published on 06 Feb 2023
Transcription factor E2F8 is a therapeutic target in the basal-like subtype of breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1038787
- 16,404 views
- 10 citations



